Jefferies raises Summit Therapeutics' target price to $30 from $25
SMMT•Jefferies raised its target price for Summit Therapeutics to $30 from $25.
Related News
Australia's central bank raises cash rate to 15-year peak
TLT•
Newmark names Mike Whitaker group chief information officer
NMRK•
Tungray Technologies files Form 3 for interim CEO Du Liling
TRSG•
Trump reportedly denies offering Iran sanctions relief for nuclear concessions
SPY•
Hengrui Pharma licenses GLP-1/GIP drug HRS-1596 to Novo Nordisk in deal worth up to USD 2.6 billion
NVO•